Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.
Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis.
Hunting for autoantibodies in multiple sclerosis.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients.
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
The Outlook for Alemtuzumab in Multiple Sclerosis.
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study.
Fast computation of myelin maps from MRI T2 relaxation data using multicore CPU and graphics card parallelization.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
[Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders].
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
Long-term safety of azathioprine therapy in multiple sclerosis.
Neuromyelitis optica: a positive appraisal of seronegative cases.
Cuprizone does not induce CNS demyelination in nonhuman primates.
Association between smoking and cognitive impairment in multiple sclerosis.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
[Evolution of Devic's neuromyelitis optica spectrum disorders.]
Pages
« first
‹ previous
…
573
574
575
576
577
578
579
580
581
…
next ›
last »